Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RNA Profile”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Large-scale testing (Phase 3)Study completedNCT05122234
What this trial is testing

Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19

Who this might be right for
COVID-19
Indonesia University 40
Early research (Phase 1)Study completedNCT00781976
What this trial is testing

Antiviral Activity of AZD7295 in HCV Carriers

Who this might be right for
Hepatitis C
Arrow Therapeutics 31
Post-approval studies (Phase 4)WithdrawnNCT01770223
What this trial is testing

Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC
Not applicableUnknownNCT03130296
What this trial is testing

Genotyping FcɣRs Genes of HIV-1 Patients "Progressor": Correlation With the Changing Profile of the Infection

Who this might be right for
HIV Infection
University Hospital, Strasbourg, France 230
Post-approval studies (Phase 4)Study completedNCT00562484
What this trial is testing

The Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy Adults

Who this might be right for
Influenza
Seqirus 7,500
Not applicableLooking for participantsNCT05610436
What this trial is testing

Post-Covid Condition Cohort: Evolution of Symptomatology, Patient Profile and Associated Prognostic Factors

Who this might be right for
Long COVIDPost-Acute COVID-19Post-Acute COVID19 Syndrome
Central Hospital, Nancy, France 500
Not applicableEnded earlyNCT03197805
What this trial is testing

Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients

Who this might be right for
Breast Cancer
Centre Jean Perrin 26
Not applicableStudy completedNCT02323308
What this trial is testing

Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination

Who this might be right for
HIV InfectionHepatitis B
ANRS, Emerging Infectious Diseases 55
Early research (Phase 1)Study completedNCT00906256
What this trial is testing

Clinical Pharmacology Study of AZD7295 in Healthy Subjects

Who this might be right for
Healthy
Arrow Therapeutics 16
Large-scale testing (Phase 3)Study completedNCT04537234
What this trial is testing

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older

Who this might be right for
Influenza (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 165
Not applicableLooking for participantsNCT06831292
What this trial is testing

The Effects of Diet on Small Non-coding RNA I Sperm Cells and the Possible Effects on Reproductive Success: Diet Intervention Effects on Sperm

Who this might be right for
Changes in SncRNA in SpermMale FertilityRNA Profile
Ostergotland County Council, Sweden 100
Not applicableStudy completedNCT00540111
What this trial is testing

Effect of Soluble Fiber on Hypertriglyceridemia and Immune Profile in HIV-positive Individuals.

Who this might be right for
HypertriglyceridemiaHIV Infections
UPECLIN HC FM Botucatu Unesp 19
Post-approval studies (Phase 4)Looking for participantsNCT06527534
What this trial is testing

Filgotinib Effect on Proteomic Profile and Micro-RNA Expression in Patients With Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Universita di Verona 30
Not applicableNot Yet RecruitingNCT06846645
What this trial is testing

Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA. a Prospective Study Will Evaluate the Performance of Direct LS-TA in Triage Febrile Patients Into Major Categories of Infections: Viral, Bacterial or Active Tuberculosis.

Who this might be right for
Single Cell Sequencing TechnologyGene Expression ProfilingGene Expression+7 more
Chinese University of Hong Kong 200
Testing effectiveness (Phase 2)Ended earlyNCT03827200
What this trial is testing

A Study Evaluating the Utility of Ambrisentan in Lowering Portal Pressure in Patients With Liver Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionAscites
Noorik Biopharmaceuticals AG 19
Early research (Phase 1)Study completedNCT04382066
What this trial is testing

Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19

Who this might be right for
COVID-19
PharmaMar 46
Testing effectiveness (Phase 2)Ended earlyNCT04900038
What this trial is testing

A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults

Who this might be right for
HIV Infections
ViiV Healthcare 85
Not applicableStudy completedNCT04685447
What this trial is testing

Effects of Different Dialysis Strategies on Inflammation in COVID-19 Maintenance Hemodialysis Patients

Who this might be right for
Covid19Hemodialysis ComplicationInflammatory Response
Universita degli Studi di Genova 30
Not applicableStudy completedNCT00002260
What this trial is testing

An Open-Label, Crossover Study to Assess the Effect of Food on the Oral Bioavailability and Pharmacokinetic Profile of 3'-Deoxy-3'-Fluorothymidine (FLT) in Asymptomatic Human Immunodeficiency Virus (HIV)-Infected Subjects

Who this might be right for
HIV Infections
Lederle Laboratories
Early research (Phase 1)Study completedNCT00771823
What this trial is testing

Maraviroc 300 mg Twice Daily in HIV Negative Male Volunteers

Who this might be right for
HIV Infections
St Stephens Aids Trust 16
Load More Results